EVE
EVE is a wheeled humanoid torso robot developed by 1X Technologies (formerly Halodi Robotics) in Norway. Standing approximately 160cm tall on a wheeled base with 16 degrees of freedom and up to 8 hours of battery life, EVE features soft actuators for safe human interaction. It has been commercially deployed since 2022 in security and service roles, including in Andoya, Norway. EVE was 1X's pioneering commercial platform and predecessor to the bipedal Neo Beta and NEO Gamma robots, targeting logistics, security, and facility management applications.
Primary use case: commercial
Height
183 cm
Weight
83 kg
DOF
25
Payload
15 kg
Battery
4 hrs
Specifications
Physical
Height
183 cm
Weight
83 kg
Degrees of Freedom
25
Locomotion
wheeled
Manipulation
Payload
15 kg
Power & Autonomy
Battery Life
4 hrs
Charging Time
3 hrs
Commercial
Availability
commercial
Primary Use Case
commercial
Related news
The FCC just cleared its first foreign factory robots, from ATi Robotics
Swiss startup Embodied AI launches AIR, a humanoid robot that learns from factory workers
Swiss aircraft manufacturer testing a humanoid robot inspector on its PC-24 assembly line
Agility is public: the short list of humanoid robot stocks, and who's next
Toyota Robotics: Toyota just established a dedicated robotics division
Wandercraft Signs 12 Enterprise Customers for Calvin-40 Industrial Humanoid
Wandercraft has secured 12 enterprise customers for its Calvin-40 industrial humanoid robot, expanding beyond its initial automotive base into logistics, retail, defense, and healthcare sectors. The Paris-based company is simultaneously working with Goldman Sachs to raise approximately €100 million ($116 million) at a €750 million valuation to scale production. The company leverages its decade-long experience in medical exoskeletons (Atalante X and Eve) to offer heavy-payload material handling capabilities in industrial environments.
Wandercraft Seeks €100M at €750M Valuation to Scale Industrial Humanoid Ambitions
Wandercraft, a Parisian robotics firm, is seeking approximately €100 million ($116 million) in new equity funding with Goldman Sachs, targeting a pre-money valuation near €750 million. The funding will support the commercial expansion of its medical exoskeletons and the manufacturing ramp-up of the Calvin industrial humanoid platform, which already has committed deployment plans from Renault (350 units) and SAPA. This raise highlights a broader financing wave sweeping Europe's robotics ecosystem as automakers race to automate factory floors.
Masayoshi Son’s $6 Billion 1X Bet Marks His Grand Return to the Humanoid Robot Sector
Masayoshi Son's SoftBank Group is in talks to acquire a majority stake in 1X Technologies at a valuation of 6 billion US dollars, marking SoftBank's return to the humanoid robot sector after selling Boston Dynamics. 1X's flagship product NEO is a bipedal household robot priced at $20,000 with a monthly subscription, designed to operate safely alongside families.
